Effect of Chronic Rhinosinusitis on the Risk of Development of Rheumatoid Arthritis.

IF 4.1 2区 医学 Q2 ALLERGY Allergy, Asthma & Immunology Research Pub Date : 2023-09-01 DOI:10.4168/aair.2023.15.5.647
Il Hwan Lee, Hee Gyu Yang, Seung-Su Ha, Gil Myeong Son, Dae Woo Kim, Dong-Kyu Kim
{"title":"Effect of Chronic Rhinosinusitis on the Risk of Development of Rheumatoid Arthritis.","authors":"Il Hwan Lee,&nbsp;Hee Gyu Yang,&nbsp;Seung-Su Ha,&nbsp;Gil Myeong Son,&nbsp;Dae Woo Kim,&nbsp;Dong-Kyu Kim","doi":"10.4168/aair.2023.15.5.647","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Several studies have reported a possible link between chronic rhinosinusitis (CRS) and rheumatoid arthritis (RA). However, it remains unclear whether CRS could influence the risk of developing RA. Therefore, in this study, we focused on examining the association between CRS and RA.</p><p><strong>Methods: </strong>A total of 14,867 individuals with CRS and 14,867 without CRS were enrolled after 1:1 propensity score match from a nationwide longitudinal cohort database in South Korea. RA incidence was assessed using person-years at risk, and the hazard ratio (HR) was examined using the Cox proportional hazards model.</p><p><strong>Results: </strong>The incidence of RA (per 1,000 person-years) was 6.51 for those with CRS, 6.55 for those with CRS without nasal polyps (CRSsNP), and 5.96 for those with CRS with nasal polyps (CRSwNP). We found that CRS individuals had a significantly increased risk of subsequent RA development with an adjusted HR of 1.41, regardless of the phenotype (adjusted HR was 1.42 in CRSsNP and 1.37 in CRSwNP patients). Moreover, the risk of developing RA over time was relatively higher within the first 4 years after the diagnosis of CRS.</p><p><strong>Conclusions: </strong>Our nationwide population-based cohort study suggests that CRS may be associated with a subsequent increase in RA events, regardless of the phenotype. Therefore, physicians should consider RA risk when diagnosing and treating CRS patients.</p>","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"15 5","pages":"647-658"},"PeriodicalIF":4.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/80/aair-15-647.PMC10570781.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2023.15.5.647","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: Several studies have reported a possible link between chronic rhinosinusitis (CRS) and rheumatoid arthritis (RA). However, it remains unclear whether CRS could influence the risk of developing RA. Therefore, in this study, we focused on examining the association between CRS and RA.

Methods: A total of 14,867 individuals with CRS and 14,867 without CRS were enrolled after 1:1 propensity score match from a nationwide longitudinal cohort database in South Korea. RA incidence was assessed using person-years at risk, and the hazard ratio (HR) was examined using the Cox proportional hazards model.

Results: The incidence of RA (per 1,000 person-years) was 6.51 for those with CRS, 6.55 for those with CRS without nasal polyps (CRSsNP), and 5.96 for those with CRS with nasal polyps (CRSwNP). We found that CRS individuals had a significantly increased risk of subsequent RA development with an adjusted HR of 1.41, regardless of the phenotype (adjusted HR was 1.42 in CRSsNP and 1.37 in CRSwNP patients). Moreover, the risk of developing RA over time was relatively higher within the first 4 years after the diagnosis of CRS.

Conclusions: Our nationwide population-based cohort study suggests that CRS may be associated with a subsequent increase in RA events, regardless of the phenotype. Therefore, physicians should consider RA risk when diagnosing and treating CRS patients.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性鼻窦炎对类风湿性关节炎发展风险的影响。
目的:几项研究报告了慢性鼻窦炎(CRS)和类风湿性关节炎(RA)之间的可能联系。然而,目前尚不清楚CRS是否会影响患RA的风险。因此,在本研究中,我们重点研究了CRS和RA之间的关系。方法:在韩国全国纵向队列数据库中,对14867名患有CRS和14867名未患有CRS的个体进行了1:1的倾向评分匹配。RA的发生率采用人-年风险评估,风险比(HR)采用Cox比例风险模型进行检查。结果:CRS患者的RA发生率(每1000人-年)为6.51,无鼻息肉CRS患者为6.55,有鼻息肉CRS的患者为5.96。我们发现,无论表型如何,CRS个体随后发生RA的风险显著增加,调整后的HR为1.41(CRSsNP患者的调整后HR为1.42,CRSwNP患者的校正后HR为1.37)。此外,在CRS诊断后的前4年内,随着时间的推移,患RA的风险相对较高。结论:我们的全国性人群队列研究表明,无论表型如何,CRS都可能与随后RA事件的增加有关。因此,医生在诊断和治疗CRS患者时应考虑RA风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
6.80%
发文量
53
审稿时长
>12 weeks
期刊介绍: The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
期刊最新文献
Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma. Neutrophil Extracellular Traps as a Biomarker in Refractory Non-Type 2 CRSwNP. Oral Administration of Lactococcus lactis Expressing Mite and Cockroach Major Allergens Alleviates Progression of Atopic March in a Mouse Model. Skin Lipid Barrier: Structure, Function and Metabolism. Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1